MIR31HG may promote cell growth and migration in lung, oral, or thyroid cancer cells [65,66,67], via the C/EBP/Wnt5A or MAP-kinase signaling pathways, depending on the specific cell types [65,67]. Here, CEBPA is linked to thyroid cancer.